Keiretsu Capital is the exclusive worldwide fund partner of Keiretsu Forum and manages angel co-investment, blockchain, and real estate funds for its investors.The firm is headquartered in Seattle, Washington and was founded in April 2007 by Matthew Le Merle, Matthew Le Merle, Nathan McDonald, and Randy Williams. Keiretsu Capital has more than 50 chapters in North America, Europe, Asia, and Australia consisting of over 3,000 angel investors.
Keiretsu Capital has made 80 investments, 2 lead investments, and 4 exits. Notable investments made by the firm include: Embera Neuro Therapeutics, Astarte Medical, Toma Biosciences, Beta Hatch, Alpin, SHM Control, Zive, Fairway America, Phytelligence, Picmonic, Savara Pharmaceuticals, Crowd Mics, and OtoSense.
